| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Litton Bionetics, Kensington, Maryland 20795 [D. H. L.], and Immunology [S. A. R., W. D. T.] and Biometry Branches [R. J. C.], National Cancer Institute, Bethesda, Maryland 20014
The immunoprophylactic effects of i.p. administration of Bacillus Calmette-Guérin (BCG) and methanol-extracted residue of BCG (MER) on the production of tumors by 3-methylcholanthrene (MCA) in C57BL/6 mice were investigated. At the dose level of MCA used (500 µg i.m.), almost all mice developed tumors. Pretreatment of the mice with BCG either 2 weeks before or 2 weeks after carcinogen administration provided a significant temporary protection, demonstrated by a decreased rate of tumor appearance. Administration of MER at a 0.5-mg dose level conferred relatively little protection against tumor production. In those mice receiving 2.5 mg MER, either on the day of carcinogen administration or both at that time and when the first experimental tumor was found, significant temporary protection against MCA carcinogenesis was obtained. This was demonstrated by a lengthened latent period before tumor production, although subsequently the rate of tumor production was similar to that of the controls.
It is concluded that BCG and MER are capable of affecting the induction of MCA-induced tumors.
1 This investigation was supported by Contract NIH-NCI-G-70-2207 from the National Cancer Institute.
2 To whom requests for reprints should be sent.
Received 8/ 7/72. Accepted 11/22/72.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |